Smoking cessation: Techniques and benefits

Clinics in Chest Medicine

Volumn 21, Issue 1, 2000, Pages 199-208

  Lillington, Glen A ^a,b   Leonard, Colm T ^b   Sachs, David P L ^a,b  

^a Palo Alto Center for Pulmonary Disease Prevention   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; MECAMYLAMINE; NICOTINE; NICOTINE GUM;

BEHAVIOR MODIFICATION; BRAIN INJURY; CIGARETTE SMOKING; DEPENDENT PERSONALITY DISORDER; LUNG DISEASE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SELF CONTROL; SMOKING CESSATION; WITHDRAWAL SYNDROME;

EID: 0034079638     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70018-6     Document Type: Article

References (59)

1. American Psychiatric Association Nicotine-induced disorder Diagnostic and Statistical Manual of Mental Disorders ed 4 1994 American Psychiatric Association Washington, DC 244 245
2. American Psychiatric Association Practice guideline for the treatment of patients with nicotine dependence Am J Psychiatry 153 suppl 1996 1 31
3. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 152 Suppl 1995 S78 121
4. 1: The Lung Health Study JAMA 272 1994 1497 1505
5. N.L. Benowitz Cigarette smoking and nicotine addiction Med Clin North Am 76 1992 415 437
6. N.L. Benowitz Nicotine safety and toxicity 1998 Oxford University Press New York
7. N.L. Benowitz S.G. Gourlay Cardiovascular toxicity of nicotine: Implications for nicotine replacement J Am Coll Cardiol 29 1997 1422 1431
8. T. Blöndal L.J. Gudmundsson I. Olafsdottir Nicotine nasal spray with nicotine patch for smoking cessation: Randomised trial with 6 year follow up Br Med J 318 1999 285 289
9. A.E. Camili B. Burrows R.J. Knudson Longitudinal changes in forced expiratory volume in one second in adults: Effects of smoking and smoking cessation Am Rev Respir Dis 135 1987 794 799
10. 2 receptor (DRD2) gene: A genetic risk factor for smoking Pharmacogenetics 6 1996 73 79
11. L.S. Covey A.H. Glassman F. Steiner Depression and depressive symptoms in smoking cessation Compr Psychiatry 31 1990 350 354
12. J. Cromwell J. Bartosch M.C. Fiore Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation JAMA 278 1997 1759 1766
13. L.C. Dale R.D. Hurt K.P. Offord High-dose nicotine patch therapy: Percentage of replacement and smoking cessation JAMA 274 1995 1353 1358
14. K.M. Eberman C.A. Patten L.C. Dale Counseling patients to quit smoking: What to say, when to say it, and how to use your time to advantage Postgrad Med 104 1998 89 94
15. K.O. Fagerström Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment Addict Behav 3 1978 235 241
16. Fiore MC, Bailey WC, Cohen SJ, et al: Smoking Cessation. AHCPR Publication No. 96-0692. Rockville, MD, US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1996 Clinical Practice Guideline No. 18.
17. Food and Drug Administration Regulations Restricting the Sale and Distribution of Cigarettes and Smokeless Tobacco to Protect Children and Adolescents: Final Rule. The Federal Register, 21 CFR Part 801, et alia 1996 US Department of Health and Human Services Washington, DC
18. P.A. Frederickson R.D. Hurt G.M. Lee High-dose transdermal nicotine therapy for heavy smokers: Safety, tolerability and measurement of nicotine and cotinine levels Psychopharmacology 122 1995 215 222
19. Glynn TJ, Manley MW: A National Cancer Institute manual for physicians. How to help your patient stop smoking. NIH Publication #92-3064, reprinted September 1992, pp 1–77.
20. S.M. Hall R.I. Herning R.T. Jones Blood cotinine levels as indicators of smoking treatment outcome Clin Pharmacol Ther 35 1984 810 814
21. J.T. Hays L.C. Dale R.D. Hurt Trends in smoking-related diseases: Why smoking cessation is still the best medicine Postgrad Med 104 1998 56 71
22. T.F. Heatherton L.T. Kozlowski R.C. Frecker The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire British Journal of Addiction 86 1991 1119 1127
23. J.E. Henningfield R.M. Keenan P.B.S. Clarke Nicotine C.R. Schuster M.J. Kuhar Pharmacologic Aspects of Drug Dependence: Toward an Integrated Neurobehavioral Approach 1996 Springer-Verlag Berlin 271 314
24. J.R. Hughes Tobacco withdrawal in self-quitters J Consult Clin Psychol 60 1992 689 697
25. J.R. Hughes Genetics of smoking: A brief review Behav Ther 17 1986 335 345
26. J.R. Hughes Treatment of smoking cessation in smokers with past alcohol/drug problems J Subst Abuse Treat 10 1993 181 187
27. J.R. Hughes D.K. Hatsukami Signs and symptoms of tobacco withdrawal Arch Gen Psychiatry 43 1986 289 294
28. J.R. Hughes D.K. Hatsukami R.W. Pickens Effect of nicotine on the tobacco withdrawal syndrome Psychopharmacology 83 1984 82 87
29. R.D. Hurt L.C. Dale P.A. Frederickson Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: 1-year outcome and percentage nicotine replacement JAMA 271 1994 595 600
30. R.D. Hurt C.R. Robertson Prying open the door to tobacco industry's secrets about nicotine: The Minnesota tobacco trial JAMA 280 1998 1173 1181
31. R.D. Hurt D.P.L. Sachs E.D. Glover A comparison of sustained-release bupropion and placebo for smoking cessation N Engl J Med 337 1997 1195 1202
32. D.E. Jorenby S.J. Leischow A.N. Mitchell A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation N Engl J Med 340 1999 685 691
33. M. Kawahara S. Ushijima T. Kamimori Second primary tumors in more than 2-year disease-free survivors of small cell lung cancer in Japan: The role of smoking cessation Br J Cancer 78 1998 409 412
34. J.D. Killen S.P. Fortman M.J. Telch Are heavy smokers different from light smokers: A comparison after 48 hours without cigarettes JAMA 260 1988 1581 1585
35. M. Kornitzer M. Boutsen M. Dramaix Combined use of nicotine patch and gum in smoking cessation: A placebo-controlled clinical trial Prev Med 24 1993 41 47
36. M. Law J.L. Tang An analysis of the effectiveness of interventions intended to help people stop smoking Arch Intern Med 155 1995 1933 1941
37. C.T. Leonard D.P.L. Sachs Environmental tobacco smoke and lung cancer incidence Curr Opin Pulm Med 5 1999 189 193
38. J.M. Lightwood S.A. Glantz Short-term economic and health benefits of smoking cessation: Myocardial infarction and stroke Circulation 96 1997 1089 1096
39. D. Mendez K.E. Warner P.N. Courant Has smoking cessation ceased? Expected trends in prevalence of smoking in the United States Am J Epidemiol 148 1998 249 258
40. S. Murin J. Hilbert S.J. Reilly Cigaret smoking and the lung Clin Rev Allerg Immunol 5 1987 307 361
41. R. Nemeth-Coslett J.E. Henningfield M.K. O'Keefe Nicotine gum: Dose-related effects on cigarette smoking and subjective ratings Psychopharmacology 92 1987 424 430
42. Office on Smoking and Health. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Washington, DC, US Department of Health and Human Services, DHHS Publication #CDC 90-8416, USGPO, 1990.
43. P. Paoletti E. Fornai Maggiorelli Importance of baseline cotinine plasma values in smoking cessation: Results from a double-blind study with nicotine patch Eur Respir J 9 1996 629 633
44. O.F. Pomerleau Individual differences insensitivity to nicotine: implications on genetic research on nicotine dependence Behav Gen 25 1995 161 177
45. D.S. Postma H.J. Sluiter Prognosis of chronic obstructive airways disease: The Dutch experience Am Rev Respir Dis 140 1989 S100 S105
46. J.E. Rose F.M. Behm E.C. Westman Mecamylamine combined with nicotine skin patch facilitates smoking cessation beyond nicotine patch treatment alone Clin Pharmacol Ther 56 1994 86 89
47. J.E. Rose E.C. Westman F.M. Behm Nicotine/mecamylamine combination treatment for smoking cessation Drug Development Research 38 1996 243 256
48. D.P.L. Sachs Effectiveness of the 4-mg dose of nicotine polacrilex for the initial treatment of high dependent smokers Arch Intern Med 155 1995 1973 1980
49. D.P.L. Sachs N.L. Benowitz Individualizing medical treatment for tobacco dependence Eur Respir J 9 1996 629 631
50. D.P.L. Sachs N.L. Benowitz A.G. Bostrom Percent serum replacement and success of nicotine patch therapy Am J Respir Crit Care Med 151 1995 A688
51. D.P.L. Sachs S.J. Leischow Pharmacologic approaches to smoking cessation Clin Chest Med 12 1991 769 791
52. D.P.L. Sachs U. Säwe S.L. Leischow Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling Arch Intern Med 153 1993 1881 1890
53. The Smoking Cessation Clinical Practice Guideline Panel and Staff The Agency for Health Care Policy and Research smoking cessation clinical practice guideline JAMA 275 1996 1270 1280
54. J. Stapleton Commentary: Progress on nicotine replacement therapy for smokers Br Med J 318 1999 289
55. P. Tønnesen V. Fryd M. Hansen Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking N Engl J Med 318 1988 15 18
56. P. Tønnesen P. Paoletti G. Gustavsson Higher dosage of nicotine patches increase 1-year smoking cessation rates: Results from the European CEASE trial Eur Respir J 13 1999 236 246
57. Transdermal Nicotine Study Group Transdermal nicotine for smoking cessation: Six-month results from two multicenter controlled clinical trials JAMA 266 1991 3133 3138
58. R. West P. Hajek A. McNeill Effect of bupropion on cigarette withdrawal and short-term abstinence rates in a smokers' clinic Psychopharmacology 104 1991 91 96
59. Working Group for the Study of Transdermal Nicotine in Patients with Coronary Artery Disease Nicotine replacement therapy for patients with coronary artery disease Arch Intern Med 154 1994 989 995